4/25
05:15 pm
regn
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Low
Report
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
4/25
11:44 am
regn
Regeneron (REGN) Reports Next Week: What You Should Expect [Yahoo! Finance]
Low
Report
Regeneron (REGN) Reports Next Week: What You Should Expect [Yahoo! Finance]
4/25
08:56 am
regn
UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study [Yahoo! Finance]
Low
Report
UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study [Yahoo! Finance]
4/25
08:51 am
regn
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study [Reuters]
Low
Report
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study [Reuters]
4/25
08:33 am
regn
REFILE-AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study [Yahoo! Finance]
Low
Report
REFILE-AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study [Yahoo! Finance]
4/25
08:21 am
regn
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies [Seeking Alpha]
Low
Report
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies [Seeking Alpha]
4/25
07:12 am
regn
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases [Yahoo! Finance]
Low
Report
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases [Yahoo! Finance]
4/25
07:00 am
regn
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
Low
Report
Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
4/24
01:38 pm
regn
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at TD Cowen from $1,020.00 to $1,030.00. They now have a "buy" rating on the stock.
Low
Report
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at TD Cowen from $1,020.00 to $1,030.00. They now have a "buy" rating on the stock.
4/24
10:15 am
regn
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO [Yahoo! Finance]
Low
Report
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO [Yahoo! Finance]
4/24
10:05 am
regn
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Low
Report
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
4/22
06:09 pm
regn
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT) [Yahoo! Finance]
Low
Report
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT) [Yahoo! Finance]
4/22
05:54 pm
regn
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Low
Report
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
4/20
02:02 am
regn
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
4/19
10:17 am
regn
Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution [Yahoo! Finance]
Low
Report
Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution [Yahoo! Finance]
4/18
05:03 pm
regn
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals, Inc. (REGN)
Low
Report
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals, Inc. (REGN)
4/18
11:00 am
regn
Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Low
Report
Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
4/18
08:04 am
regn
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at UBS Group AG from $1,090.00 to $1,099.00. They now have a "buy" rating on the stock.
Low
Report
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at UBS Group AG from $1,090.00 to $1,099.00. They now have a "buy" rating on the stock.
4/18
08:00 am
regn
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Low
Report
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
4/17
09:00 pm
regn
REGENERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Regeneron Pharmaceuticals, Inc. on Behalf of Regeneron Stockholders and Encourages Investors to Contact the Firm
Low
Report
REGENERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Regeneron Pharmaceuticals, Inc. on Behalf of Regeneron Stockholders and Encourages Investors to Contact the Firm
4/17
02:15 pm
regn
The Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors
Low
Report
The Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors
4/17
11:00 am
regn
Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Low
Report
Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
4/16
10:05 pm
regn
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Low
Report
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
4/16
11:00 am
regn
Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Low
Report
Regeneron Pharmaceuticals, Inc. (REGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
4/15
08:16 pm
regn
UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation [Yahoo! Finance]
Low
Report
UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation [Yahoo! Finance]